<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medbio</journal-id><journal-title-group><journal-title xml:lang="ru">Медико-биологические проблемы жизнедеятельности</journal-title><trans-title-group xml:lang="en"><trans-title>Medical and Biological Problems of Life Activity</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2088</issn><publisher><publisher-name>Республиканский научно-практический центр радиационной медицины и экологии человека</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medbio-196</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Влияние полиморфизма генов IL-1 и IL-4 на развитие хронического гастрита и рака желудка</article-title><trans-title-group xml:lang="en"><trans-title>Gene polymorphism influence of the IL-1 and IL-4I in the development of chronic gastritis and gastric cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воропаева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Voropayeva</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпенко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpenko</surname><given-names>O. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Силин</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Silin</surname><given-names>A. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бредихина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bredikhina</surname><given-names>E. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартинков</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Martinkov</surname><given-names>V. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ «РНПЦ радиационной медицины и экологии человека», г. Гомель, Беларусь</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>02</day><month>03</month><year>2023</year></pub-date><volume>0</volume><issue>1</issue><fpage>123</fpage><lpage>127</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воропаева А.В., Карпенко О.В., Силин А.Е., Бредихина Е.В., Мартинков В.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Воропаева А.В., Карпенко О.В., Силин А.Е., Бредихина Е.В., Мартинков В.Н.</copyright-holder><copyright-holder xml:lang="en">Voropayeva A..., Karpenko O..., Silin A..., Bredikhina E..., Martinkov V...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medbio.ejournal.by/jour/article/view/196">https://medbio.ejournal.by/jour/article/view/196</self-uri><abstract><p>При изучении взаимосвязи полиморфизма генов IL-1 и IL-4 с хроническим гастритом и раком желудка установлены следующие региональные особенности: Наличие у пациента генотипа 1/1 IL-1RN повышает риск развития рака желудка в 2,2 раза (р= 0,003, ОШ = 2,21, 95% ДИ 1,29-3,76 ); генотипа СT IL-4 С-33Т в 21 раз; Наличие генотипа 2/2 IL-1RN повышает риск развития хронического гастрита умеренно или высокой степени активности в 2,3 раза (р =0,021, ОШ = 2,37, 95% ДИ 1,12-5,02); Наличие у пациента генотипа СТ IL-1? C-511T и генотипа 2/2 IL-1 RN повышает риск инфицирования обладающими онкогенным потенциалом сagA штаммами H. pylori в 2,2 раза ( р=0,005, ОШ = 2,21, 95% ДИ 1,29-3,76) и (р=0,034, ОШ = 2,2, 95% ДИ 1,05-4,62). Носители данных полиморфных локусов с целью ранней диагностики неблагоприятного заболевания нуждаются в диспансерном наблюдении и обязательном обследовании.</p></abstract><trans-abstract xml:lang="en"><p>When studying the relationship of polymorphism of genes IL-1 and IL-4 with chronic gastritis and gastric cancer we established the following regional particularities: If the patient has genotype 1/1 IL-1RN the risk of stomach cancer increases 2,2 times (p=0,003, OR=2,21, 95% CI 1,29-3,76); CT genotype IL-4 in C-33T 21 times; The presence of genotype 2/2 IL- 1RN increases the risk of chronic gastritis moderate or high activity of 2,3 times (p=0,021, OR=2,37, 95% CI 1,12 -5,02); If the patient has CT genotype IL-1? C-511T and genotype 2/2 IL-1 RN it increases the risk of infection having oncogenic potential сagA H. pylori strains in 2,2 times (p=0,005, OR=2,21, 95% CI 1,29-3,76) (p=0,034, OR=2,2, 95% CI 1,05-4,62). Data carriers of polymorphic loci for early detection of adverse disease require dispensary observation and inspection mandatory.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>полиморфизм генов</kwd><kwd>интерлейкин</kwd><kwd>генотип</kwd><kwd>заболевания желудка</kwd><kwd>инфекция Helicobacter pylori</kwd><kwd>gene polymorphism</kwd><kwd>interleukin</kwd><kwd>genotype</kwd><kwd>diseases of the stomach</kwd><kwd>Helicobacter pylori infection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection / R. Rad [et al.] // Gut. - 2004. - № 53. - P.1082-1089.</mixed-citation><mixed-citation xml:lang="en">Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection / R. Rad [et al.] // Gut. - 2004. - № 53. - P.1082-1089.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Interleukin-1 polymorphisms associated with increased risk of gastric cancer / E.M. El-Omar [et al.] // Nature. - 2000. - Vol. 404. - P. 398-402.</mixed-citation><mixed-citation xml:lang="en">Interleukin-1 polymorphisms associated with increased risk of gastric cancer / E.M. El-Omar [et al.] // Nature. - 2000. - Vol. 404. - P. 398-402.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">IL-1 beta pro-inflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy / T. Ando [et al.] // GUT. - 2006. - Vol. 55, N 2. - P.158-164.</mixed-citation><mixed-citation xml:lang="en">IL-1 beta pro-inflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy / T. Ando [et al.] // GUT. - 2006. - Vol. 55, N 2. - P.158-164.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Effect of genetic polymorphism Inteleukin-1? on gastritis, gastric juice pH, and recurrence of peptic ulcerdisease in Japanese subjects / T. Furuta [et al.] // Gastroenterology. - 2002. - Vol. 123, N 1. - P. 92-105.</mixed-citation><mixed-citation xml:lang="en">Effect of genetic polymorphism Inteleukin-1? on gastritis, gastric juice pH, and recurrence of peptic ulcerdisease in Japanese subjects / T. Furuta [et al.] // Gastroenterology. - 2002. - Vol. 123, N 1. - P. 92-105.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">El-Omar, E.M. The importance of interleukin I beta in Helicobacter pylori associated disease / E.M. El-Omar // Gut. - 2001. - № 48. - P. 743-747.</mixed-citation><mixed-citation xml:lang="en">El-Omar, E.M. The importance of interleukin I beta in Helicobacter pylori associated disease / E.M. El-Omar // Gut. - 2001. - № 48. - P. 743-747.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Маев, И.В. Аллельный полиморфизм интерлейкина-1? при геликобактериозе / И.В. Маев, Ю.А. Кучерявый, Т.С. Оганесян // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2008. - Т.18, №5. - С. 4-11.</mixed-citation><mixed-citation xml:lang="en">Маев, И.В. Аллельный полиморфизм интерлейкина-1? при геликобактериозе / И.В. Маев, Ю.А. Кучерявый, Т.С. Оганесян // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2008. - Т.18, №5. - С. 4-11.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Interleukin-2 Gene Polymorphisms Associated with Increased Risk of Gastric Atrophy from Helicobacter pylori Infection / Sh. Togawa [et al.] // Helicobacter. - 2005. - Vol. 10, N. 3. - P.172-178</mixed-citation><mixed-citation xml:lang="en">Interleukin-2 Gene Polymorphisms Associated with Increased Risk of Gastric Atrophy from Helicobacter pylori Infection / Sh. Togawa [et al.] // Helicobacter. - 2005. - Vol. 10, N. 3. - P.172-178</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Association between IL-4 genotype and IL-4 production in the Japanese population / H. Nakashima [et al.] // Genes Immun. - 2002. - N.3. - P. 107-109.</mixed-citation><mixed-citation xml:lang="en">Association between IL-4 genotype and IL-4 production in the Japanese population / H. Nakashima [et al.] // Genes Immun. - 2002. - N.3. - P. 107-109.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population / A.M. Sampaio [et al.] // GE Portuguese Journal of Gastroenterology. - 2015. - Vol. 22, Issue 4. - P. 143-152.</mixed-citation><mixed-citation xml:lang="en">Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population / A.M. Sampaio [et al.] // GE Portuguese Journal of Gastroenterology. - 2015. - Vol. 22, Issue 4. - P. 143-152.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
